Various agents are available for the treatment of vulvovaginal candidiasis. Imidazole agents (clotrimazole, miconazole, butoconazole, and terconazole) are preferred because of their greater efficacy, shorter treatment regimens, and ease of administration. Although the various imidazole compounds are equaly efficacious, different treatment schedules are recommended depending on clinical situations. Additionally, different formulations are available that provide clinicians and patients with the opportunity to select the most appropriate agent.
Get full access to this article
View all access options for this article.
References
1.
JacobsonJB. Current thinking on the pathogenesis of vulvovaginal candidiasis.J Reprod Med1986; 31(suppl 7): 6456.
2.
BrownDJr., HenzlMR, LepageMEButoconazole vaginal cream in the treatment of vulvovaginal candidiasis: comparison with miconazole nitrate and placebo.J Reprod Med1986; 31: 10458.
3.
KaufmanRH. Vulvovaginal candidiasis: a symposium.J Reprod Med1986; 31(suppl 7): 63940.
4.
HenzlMR. Vulvovaginal candidiasis: historical perspectives and current trends.J Reprod Med1986; 31(suppl 7): 6414.
5.
O'CONNORMI, SobelJD, Epidemiology of recurrent vulvovaginal candidiasis: identification and strain differentiation of Candida albicans.J Infect Dis1986; 154: 35863.
6.
MilneJD, WarnockDW. Effect of simultaneous oral and vaginal treatment on the rate of cure and relapse in vaginal candidosis.Br J Vener Dis1979; 55: 3625.
7.
MilsomI, ForssmanL.Repeated candidiasis: reinfection or recrudescence? A review.Am J Obstet Gynecol1985; 152(suppl 7 pt 2): 9569.
8.
Nystatin Multicenter Study Group,. Therapy of candidal vaginitis: the effect of eliminating intestinal Candida.Am J Obstet Gynecol1986; 155: 6515.
BrownDJr.Therapeutic alternatives and new treatment modalities in vulvovaginal candidiasis.J Reprod Med1986; 31(suppl 7): 6534.
20.
MilneLJR. The antifungal imidazoles: clotrimazole and miconazole.Scot Med J1978; 23: 14952.
21.
RobertsonWH. Patient compliance and the short-term treatment regimen.Chemotherapy1982; 28(suppl 1): 806.
22.
TooleyPJH. Patient and doctor preferences in the treatment of vaginal candidosis.Practitioner1985; 229: 65560.
23.
Plempelm. On the action kinetics of clotrimazole.Chemotherapy1982; 28(suppl 1): 2231.
24.
TolmanEL, IsaacsonDM, RosenthaleMEAnticandidal activities of terconazole, a broad-spectrum antimycotic.Antimicrob Agents Chemother1986; 29: 98691.
25.
BlochB, SmytheE.Ketoconazole in the treatment of vaginal candidiasis.S Afr Med J1985; 67: 1789.
26.
BinghamJS. Single blind comparison of ketoconazole 200 mg oral tablets and clotrimazole 100 mg vaginal tablets and 1% cream in treating acute vaginal candidosis.Br J Vener Dis1984; 60: 1757.
27.
SalemHT, SalahM, FaridA, SabraAM, MakaremMH. Oral versus local treatment of vaginal candidosis.Int J Gynecol Obstet1989; 30: 5762.
28.
MccueJD. Evaluation and management of vaginitis: an update for primary care practitioners.Arch Intern Med1989; 149: 5658.
29.
SobelJD, SchmittC, MeriwetherC.Clotrimazole treatment of recurrent and chronic Candida vulvovaginitis.Obstet Gynecol1989; 73(suppl 3 pt 1): 3304.
30.
Butoconazole nitrate. In: McEvoyGK, ed. American hospital formulary service drug information 89.Bethesda, MD: American Society of Hospital Pharmacists, 1989; 19345.
31.
GelmanR, RumackBH, eds. Butoconazole drug evaluation. In: DRUGDEX information system. Vol. 65. Denver, CO: Micromedex, Aug 1987; exp. Aug 31, 1990.
OddsFC, WebsterCE, AbbottAB. Antifungal relative inhibition factors: BAY 1-9139, bifonazole, butoconazole, isoconazole, itraconazole (R-51211), oxiconazole, RO 14-4767/002, sulconazole, terconazole, and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.J Antimicrob Chemother1984;14: 10514.
37.
BerganT, VangdalM.In vitro activity of antifungal agents against yeast species.Chemotherapy1983; 29: 10410.
38.
SchallerK.In vitro antibacterial activity of different clotrimazole formulations.Chemotherapy1982; 28(suppl 1): 326.
39.
RitterW, PatzschkeK, KrauseU, StettendorfS.Pharmacokinetic fundamentals of vaginal treatment with clotrimazole.Chemotherapy1982; 28(suppl 1): 3742.
40.
MendlingW, PlempelM.Vaginal secretion levels after 6 days, 3 days and 1 day of treatment with 100, 200, and 500 mg vaginal tablets of clotrimazole and their therapeutic efficacy.Chemotherapy1982; 28(suppl 1): 437.
41.
KrauseU.Results of single-dose treatment of vaginal mycoses with 500 mg Canesten vaginal tablets.Chemotherapy1982; 28(suppl 1): 99105.
42.
GoormansE, BergsteinNAM, LoenderslootEW, BranolteJH. One-dose therapy of Candida vaginitis: I. results of an open multicentre trial.Chemotherapy1982; 28(suppl 1): 1069.
43.
WolfsonN, HodgsonC.Clinical toxicology of one-day administration of 500 mg of clotrimazole.J La State Med Soc1987; 139: 358.
44.
HughesD, KriedmanT.Treatment of vulvovaginal candidiasis with a 500-mg vaginal tablet of clotrimazole.Clin Ther1984; 6: 6628.
45.
MilsomI, ForssmanL.Treatment of vaginal candidosis with a single 500-mg clotrimazole pessary.Br J Vener Dis1982; 58: 1246.
46.
CohenL.Treatment of vaginal candidosis using clotrimazole vaginal cream: single dose versus 3-day therapy.Curr Med Res Opin1985; 9: 5203.
CohenL.Is more than one application of an antifungal necessary in the treatment of acute vaginal candidiasis?Am J Obstet Gynecol1985; 157(7 pt 2): 9614.
49.
LebherzT, GuessE, WolfsonN.Efficacy of single- versus multiple-dose clotrimazole therapy in the management of vulvovaginal candidiasis.Am J Obstet Gynecol1985; 152(7 pt 2): 9658.
50.
FleuryF, HughesD, FloydR.Therapeutic results obtained in vaginal mycoses after single-dose treatment with 500 mg clotrimazole vaginal tablets.Am J Obstet Gynecol1985; 152(suppl 7 pt 2): 9670.
RobertsonWH. Vulvovaginal candidiasis treated with clotrimazole cream in seven days compared with fourteen-day treatment with miconazole cream.Am J Obstet Gynecol1978; 132: 3213.
54.
MayhewSR, SuffieldWE. Candidal vaginitis: a study of the efficacy of a reduced duration treatment with miconazole nitrate.Practitioner1979; 222: 5647.
55.
WolfsonN, SamuelsB, RileyJ.A three-day treatment regimen for vulvovaginal candidiasis.J La State Med Soc1982; 134: 2831.
56.
MizunoS, ChoN.Clinical evaluation of three-day treatment of vaginal mycosis with clotrimazole vaginal tablets.J Int Med Res1983; 11: 17985.
57.
RobertsonWH. A concentrated therapeutic regimen for vulvovaginal candidiasis.JAMA1980; 244: 254950.
PasqualeSA, LawsonJ, SargentEC, NewdeckJP. A dose-response study with Monistat cream.Obstet Gynecol1979; 53: 2503.
64.
SchnellJD. Epidemiology and the prevention of peripartal mycoses.Chemotherapy1982; 28(suppl 1): 6672.
65.
FrerichW, GadA.The frequency of Candida infections in pregnancy and their treatment with clotrimazole.Curr Med Res Opin1977; 4: 6404.
66.
DavisJE, FrudenfeldJH, GoddardJL. Comparative evaluation of Monistat and Mycostatin in the treatment of vulvovaginal candidiasis.Obstet Gynecol1974; 44: 4036.
67.
DunsterGD. Vaginal candidiasis in pregnancy—a trial of clotrimazole.Postgrad Med J1974; 50(suppl 1): 869.
68.
KjaeldgaardA, LarssonB.Single-blind comparative clinical trial of short-term therapy with terconazole versus clotrimazole vaginal tablets in vulvovaginal candidiasis.Curr Ther Res1985; 38: 93944.
69.
KjaeldgaardA.Comparison of terconazole and clotrimazole vaginal tablets in the treatment of vulvovaginal candidosis.Pharmatherapeutica1986; 4: 52531.
A comparison of single-dose oral fluconazole with 3-day intravaginal clotrimazole in the treatment of vaginal candidiasis: report of an international multicentre trial.Br J Obstet Gynaecol1989; 96: 22632.
